HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alessandro Capucci Selected Research

Flecainide (Tambocor)

10/2019Flecainide: Electrophysiological properties, clinical indications, and practical aspects.
1/2018To the Editor- Flecainide and propafenone: Good twins for premature ventricular contractions' killing but not exactly superimposable.
11/2016Flecainide-metoprolol combination reduces atrial fibrillation clinical recurrences and improves tolerability at 1-year follow-up in persistent symptomatic atrial fibrillation.
4/2012Safety of flecainide.
2/2011Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation.
4/2010Intravenous administration of flecainide or propafenone in patients with recent-onset atrial fibrillation does not predict adverse effects during 'pill-in-the-pocket' treatment.
7/2005Predictors of atrial antitachycardia pacing efficacy in patients affected by brady-tachy form of sick sinus syndrome and implanted with a DDDRP device.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alessandro Capucci Research Topics

Disease

46Atrial Fibrillation
01/2022 - 01/2002
19Heart Failure
01/2022 - 01/2002
13Stroke (Strokes)
12/2020 - 03/2004
10Cardiac Arrhythmias (Arrythmia)
10/2019 - 01/2005
8Myocardial Infarction
01/2022 - 07/2005
7Hypertension (High Blood Pressure)
10/2019 - 12/2003
6Ventricular Tachycardia
10/2019 - 02/2012
5Left Ventricular Dysfunction
01/2022 - 01/2002
5Tachycardia (Tachyarrhythmias)
10/2019 - 01/2005
5Ventricular Fibrillation
10/2019 - 02/2012
4Heart Diseases (Heart Disease)
01/2020 - 12/2003
4Bradycardia
08/2008 - 01/2004
3Sleep Apnea Syndromes (Sleep Apnea)
01/2022 - 01/2018
3Cardiomyopathies (Cardiomyopathy)
10/2021 - 12/2018
3Heart Arrest (Cardiac Arrest)
10/2019 - 03/2012
3Shock
12/2018 - 07/2004
3Cardiac Sudden Death (Sudden Cardiac Arrest)
01/2018 - 08/2002
3Sudden Death
11/2017 - 07/2005
3Atrial Flutter (Flutter, Atrial)
12/2014 - 01/2002
2Syncope (Fainting)
01/2022 - 03/2004
2Systolic Heart Failure
01/2022 - 07/2019
2Neoplasms (Cancer)
01/2018 - 09/2017
2Transient Ischemic Attack
03/2012 - 03/2004
2Sick Sinus Syndrome
08/2008 - 07/2005
2Embolism (Embolus)
04/2008 - 11/2005
1MINOCA
01/2021
1Disease Progression
11/2020
1COVID-19
11/2020
1Liver Failure
12/2019
1Insulin Resistance
10/2019
1Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2019
1Weight Loss (Weight Reduction)
10/2019
1Obesity
10/2019
1Pulmonary Hypertension
01/2018
1Inflammation (Inflammations)
01/2018
1Alzheimer Disease (Alzheimer's Disease)
01/2018
1Ventricular Premature Complexes (Premature Ventricular Contraction)
01/2018
1Acute Coronary Syndrome
01/2018
1Cognitive Dysfunction
01/2018
1Coronary Artery Disease (Coronary Atherosclerosis)
12/2017
1Channelopathies
11/2017
1Peripheral Vascular Diseases (Peripheral Vascular Disease)
10/2017
1Vascular Diseases (Vascular Disease)
10/2017
1Cardiotoxicity
09/2017
1Chest Pain (Chest Pains)
02/2017
1Out-of-Hospital Cardiac Arrest
02/2016
1Ebstein Anomaly (Ebsteins Anomaly)
04/2014
1Death (Near-Death Experience)
03/2014
1Dyslipidemias (Dyslipidemia)
01/2013

Drug/Important Bio-Agent (IBA)

8DronedaroneFDA Link
12/2019 - 08/2003
7Pharmaceutical PreparationsIBA
10/2021 - 02/2004
7Anti-Arrhythmia AgentsIBA
01/2021 - 03/2008
7Flecainide (Tambocor)FDA LinkGeneric
10/2019 - 07/2005
5Amiodarone (Amiodarona)FDA LinkGeneric
02/2013 - 09/2007
4Propafenone (Rythmol)FDA LinkGeneric
01/2018 - 01/2002
3celivaroneIBA
05/2012 - 12/2011
2Metoprolol (Toprol-XL)FDA LinkGeneric
01/2022 - 11/2016
2AnticoagulantsIBA
12/2020 - 10/2018
2vernakalantIBA
09/2014 - 01/2011
1GadoliniumIBA
01/2022
1Amyloid (Amyloid Fibrils)IBA
10/2021
1Prealbumin (Transthyretin)IBA
10/2021
1Hydroxychloroquine (Plaquenil)FDA LinkGeneric
11/2020
1dicarboxydine (DCD)IBA
01/2020
1Glucose (Dextrose)FDA LinkGeneric
10/2019
1LipidsIBA
10/2019
1Biomarkers (Surrogate Marker)IBA
10/2019
1Caffeine (No Doz)FDA LinkGeneric
10/2019
1ORALIT (ORS)IBA
10/2019
1Ion Channels (Ion Channel)IBA
01/2018
1Digoxin (Digitek)FDA LinkGeneric
01/2018
1Apolipoproteins E (ApoE)IBA
01/2018
1Indicators and Reagents (Reagents)IBA
01/2018
1PotassiumIBA
01/2018
1Testosterone (Sustanon)FDA Link
01/2018
1SolutionsIBA
10/2017
1afliberceptIBA
09/2017
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2017
1EnzymesIBA
02/2017
1RanolazineFDA Link
01/2017
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2013
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2013

Therapy/Procedure

22Therapeutics
01/2021 - 01/2004
18Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
01/2022 - 07/2005
13Defibrillators (Defibrillator)
01/2022 - 02/2004
13Electric Countershock (Cardioversion)
01/2021 - 08/2003
8Cardiac Resynchronization Therapy
01/2022 - 05/2006
4Secondary Prevention
12/2018 - 03/2014
2Catheters
12/2020 - 12/2006
2Drug Therapy (Chemotherapy)
01/2018 - 05/2009
2Cardiopulmonary Resuscitation (CPR)
02/2016 - 08/2002
1Critical Care (Surgical Intensive Care)
11/2020
1Caloric Restriction
10/2019
1Ambulatory Care (Outpatient Care)
03/2016
1Resuscitation
02/2016
1Cardiac Resynchronization Therapy Devices
01/2016
1Patient Readmission
02/2015
1Transplantation
03/2014
1Heart Transplantation (Grafting, Heart)
03/2014
1Cardiomyoplasty
10/2013